Portable Testing for Sleep Disorders How to do it When to use it Pittsburgh Mind Body Center, Core D “The Pittsburgh Sleep Group (PSG)”

Slides:



Advertisements
Similar presentations
OUT OF CENTER TESTING FOR OSA: TIME TO GET SERIOUS!
Advertisements

Nursing Diagnosis in Health Care Organizations: Factors that facilitate – and complicate - implementation.
Chapter 12 - Health Care Trends and Forecasts McGraw-Hill © 2010 by The McGraw-Hill Companies, Inc. All rights reserved 12-1.
Actigraphy : A discussion of a non-invasive measurement of Sleep/Wake and Activity. Indiana Society of Sleep Professionals 7 th Annual Educational Summit.
Portable Sleep Device Survey Australia & New Zealand 2005 ASTA Amanda Piper St John of God Sleep Centre, Perth, WA.
Physical Journal Device Platform. Physical Journal Device Platform (PJDP) is the total solution for health management Physical Journal Device Platform.
Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
The ORCHID project Dr Ian Gaywood, NUH Dr Ira Pande, NUH Professor John Chelsom, City University London.
David P. Taylor, MS 1,2, Nathan C. Hulse, PhD 1,2, Grant M. Wood 2, Peter J. Haug, MD 1,2, Marc S. Williams, MD 1,2 1 University of Utah, Salt Lake City,
Contact Details Or
Sleep Technologists Health Care Professionals The American Association of Sleep Technologists (AAST) is a national health care membership association of.
Health Care Science Diagnostic Services. What is Diagnostic Services? Workers in this area help with the diagnosis of illness and diseases. They may or.
Sep 8 Fall 05 Medical Data Patient Data Clinical Data Healthcare Data Biomedical Data.
Reducing Bounce Back Lorissa MacAllister Zhuoyang Li Pramit Sengupta Georgia Tech Health System Institute Hospital to Home: Maintaining Continued Healing.
GARY HAIGH CAPACITY AND CONSENT. CONSENT Establishing consent is fundamental to respect for patients rights. It is a legal obligation.
Layering on Non-Communicable Diseases
Evidence Based Nursing Process to Practice Bracken Health Sciences Library (adapted from a presentation of Dr. Norma MacIntyre, School of Rehabilitation.
Potential Roles and Limitations of Biomarkers in Alzheimer’s Disease Richard Mayeux, MD, MSc Columbia University.
FDA Panel Comments Adele Schneider, MD, FACMG Victor Center for the Prevention of Jewish Genetic Diseases, Director, Clinical Genetics Albert Einstein.
Obstructive Sleep Apnea
Computer Science AND DOCTORS Jolena Co Truong- 6 th period.
A guide for healthcare professionals Measuring Blood Pressure at Home Michigan Department of Community Health Heart Disease and Stroke Prevention Unit.
Intercepting CKD in Primary Care
September 11, 2012 Mike Hummel Watermark Medical Obstructive Sleep Apnea (OSA) Impacting Workplace Safety and Cost.
Computer Based Physical Fitness Testing Michele Relation.
DCAC ©DCAC 2002 Organizing a Sustainable System of Care for Children with Asthma DC Asthma Coalition Lisa A. Gilmore, Project Director
Empowering Physicians to Treat Sleep Apnea The MD Home Sleep Program Presented by Dr. Avi Ishaaya, MD Medical Director.
Multiple Choice Questions for discussion
CHALLENGE CENTER Filling the Gap in the Continuum of Care.
Epidemiology Tools and Methods Session 2, Part 1.
ASH SPECIALIST PROGRAM REPORT Thomas D. Giles, MD, President of the ASH Specialist Program Inc.,
Non-communicable Diseases: Integrated Care & Health Policy Eliot Sorel, M.D. Senior Scholar, Clinical Practice Innovations Professor, Global Health, Health.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Monitoring Drug Resistant Tuberculosis Treatment in Brazil through an Innovative Web-based Information System Dr. Luis Gustavo Bastos Management Sciences.
My role Being part of the core MAGIC team for primary care Imbedding shared decision making into the culture of the surgery Writing patient decision aids(PDAs)
Dr K N Prasad Community Medicine
Unit 3: Universal Case Reporting and Sentinel Surveillance for STIs
THE EVIDENCE PRESENTED BY: STEPHEN TREGEAR, DPHIL PROGRAM DIRECTOR DIVISION OF EVIDENCE-BASED DECISION AND POLICY MAKING MANILA CONSULTING GROUP Obstructive.
Evaluating a Case of Sleep Apnoea Dr J.M. Joshi Professor and Head Department of Pulmonary Medicine T.N. Medical College B.Y.L. Nair Hospital Mumbai.
Chapter 18 by Sheldon Prial and Schuyler F. Hoss Overview of Home Telehealth.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
When is ambulatory monitoring for OSA indicated ?
AASM Quality Measures: What you need to know
Section VII. Home BP Measurement 2015 Canadian Hypertension Education Program Recommendations.
TMO Review Jin Guang Zheng, Tetherless World Constellation.
| | Healthcare Science careers.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
Jan 2002 EDMA The central role of the Medical Laboratory in a World of Managed Health An EDMA presentation of the benefits of in vitro testing as a basis.
PORTABLE MONITORING FOR THE DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA ADNAN ABBASI, MBBS, MPH.
All our comparisons will be against the apnea-hypopnea index (AHI) from the LPSG since it is the gold standard for diagnosing sleep apnea. The decision.
Date of download: 7/15/2016 From: Diagnosis and Initial Management of Obstructive Sleep Apnea without Polysomnography: A Randomized Validation Study Ann.
T.Vasilopoulos1, C.Tatsi1, C. Lionis1
Some epidemiological principles and methods
Home Sleep Testing- Open and Directed Question Session.
Oxygen Desaturation Index (ODI) Obstructive Apnoea (OA)
WHAT DOES A BIOMEDICAL TECHNICIAN DO?
Overlap syndrome (chronic obstructive pulmonary disease and respiratory sleep disorders) – experience of Pulmonology Cl. Tg. Mures, Romania Gabriela Jimborean,
NATIONAL outreach Network
Outbreak Investigations
ESAP study (simple neck grasp) as a predictor of OSA in Patients with Type 2 Diabetes Kulothungan Gunasekaran MBBS, Peter Edmonds BS, Jennifer Victory.
Title: OSA detection in children
Vesna Pekarović Džakulin
New approaches to sleep monitoring
How do we delay disease progress once it has started?
Find and Treat All Missing Persons with TB
Stroke and the obstructive Sleep Apnea patient
Introduction To Medical Technology
Diagnostic and management strategy recommended in obstructive sleep apnoea syndrome (OSAS) suspicion [52, 75–77]. Diagnostic and management strategy recommended.
MD Tech Council – Doing Biz w/ NIH
Evidence Based Diagnosis
Presentation transcript:

Portable Testing for Sleep Disorders How to do it When to use it Pittsburgh Mind Body Center, Core D “The Pittsburgh Sleep Group (PSG)”

Sleep Testing Possibilities  Questionnaires  Actigraphy  Full PSG  Other

Portable Testing What we will cover in this session Rationale Types of equipment Pros and cons of different systems Costs Examples of usage; some hands on “play” Questions/Answers

Portable Sleep Apnea Monitoring

Current State of non-Sleep Laboratory Diagnosis of OSA  Clinical suspicion Probably accurate in obvious cases but cannot be routinely relied upon Lacks sensitivity and specificity  Questionnaires Validate clinical suspicion None sufficiently sensitive or specific as a stand alone diagnostic method Are useful as an adjunct to clinical decision-making, triage – MAP, Berlin are reasonable to consider

Cardiovascular Consequences of Sleep-Disordered Breathing Report of a Workshop From the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute Circulation : Basic ScienceClinical Epidemiology Clinical Therapeutic Studies Sleep Disordered Breathing & Cardiovascular Disease Cellular / molecular studies Mouse models Pathway studies for humans High – risk patient subsets Development of new treatment approaches Develop new tools for population screening Prospective cohort studies Incorporation of SDB / Sleep Deprivation in ongoing CV cohort studies

Institute of Medicine Report 2006 What is needed?  Expand awareness among health care professionals through education and training.  Develop and validate new and existing diagnostic and therapeutic technologies.

Ability of type III monitors in the home setting to identify AHI suggestive of OSAHS in laboratory-based polysomnography Pos LR >10 Neg LR < 0.1 From Trikalinos et al, AHRQ, 07

Current State of non-Sleep Laboratory Diagnosis of OSA  Diagnostic equipment Terminology: Portable, ambulatory, out- of-sleep lab, HST, etc Types of equipment  Type 2  Type 3  Type 4

Type 2 Monitors: Mini-PSG  Advantage Multiple channels Flexibility of signal type Comprehensive Use standard software of a base system Portability Extensive track-record in research applications  Disadvantage Tech hook up Expensive Probably no reimbursement for home PSG Loss of signal – no way to easily correct problem

Type 3 Monitors: Cardio-pulmonary Studies  Advantage Easy to set up: easily done by most patients; technician not required Inexpensive (<$10K) Very portable Reduced number of signals  Disadvantage Reduced number of signals No reimbursement Signal loss at home; not way to correct Requires scoring or at least overview of scoring by tech; takes longer than you think

Type 4 Monitors: Oximetry +  Advantage Most portable Inexpensive Easy to set up Core signals: oxygenation and airflow Now may include PAT signal  Disadvantage No reimbursement Minimal number of signals – may not capture important aspects of some OSA Signal loss

Current Uncertainties: Type 3 & 4 Devices  How many signals are needed?  Which signals add the most value?  Are there clinical populations that this does not work in?  How can technology be combined with clinical decision making to optimize OSA diagnosis outside the sleep lab?

More uncertainties…  New technologies – how do they fit in to the existing PSAT device classification? WatchPAT-100 PTT ARES New systems on the horizon will have capabilities to be a level 2-4 by adding or taking away modules

Stardust  Made by Respironics, Inc  Level 3 device  Measures: airflow, resp. effort, oximetry, heart rate, body position  Well validated  Moderately expensive, ~$7000 but subsequent units are cheaper  Moderate tech time for scoring

Embletta  Somnologica/Medcare  Level 3  Measures: Airflow, respiratory effort, oximetry, body position  Well-validated, widely used  Moderately expensive, similar to Stardust  Moderate tech time for scoring

Type 3 monitor

Stardust Report

Apnea link  Resmed, Inc.  Level 4  Measures: airflow +/- oximetry  Some validation; generally shows that it’s accurate in detecting more severe OSA  Relatively inexpensive; consumables less than $15 for earlier models  Limited tech time

Example of moderate sleep apnea on Apnea Link

WatchPAT  Works on principle of changes in peripheral arterial tonometry  Indirect measure of ANS activity  PAT is a surrogate marker for apnea, hypoxia  Moderately expensive to purchase; individual probes are recurring cost  Minimal to no tech time for scoring

WatchPAT Example

Other devices  Apnea Risk Evaluation System (ARES) New unit Cardiopulmonary monitor Moderately expensive Some local experience with it Tech time minimal

Night Cap  Developed by Dr. Allan Hobson  Head cap that can measure NREM vs. REM sleep  Limited validation studies  Not used much anymore as best as I can tell  ?Commercial availability

Bodymedia -Sensewear  Bodymedia, Inc  Wearable devices that sense activity – more akin to actigraphy  Evolving more into a obesity management solution than a sleep rhythm detector

Scenario 1  Your objective is to measure psychological “well-being” in a cohort of Iraq war veterans over a 3 year span beginning with the end of military service  You are concerned that sleep disorders will be a mediator of psychological health  Your are also concerned that sleep disorders will confound the sleep measure

Scenario 1, continued  Your budget is very limited  How can you assess for sleep apnea in a cost efficient way?  How can other sleep disorders be assessed?  What tools would you use and why?

Scenario 2  Your objective is to screen a population of factory workers for sleep apnea as part of a wellness program you are consulted about  You have 2500 middle-aged men and women to screen  Your budget total budget for sleep screening is $20 per person but you can get some equipment through a different grant

Scenario 2, continued  How would you screen for sleep apnea?  What are the pros and cons?  What else do you need to know?

Scenario 3  Your objective is to measure sleep and rule out sleep apnea in a study of obese individuals contemplating bariatric surgery and stress  This is a pilot study and you have essentially no budget but you have friend who will help with the sleep part for free (within reason).

Scenario 3, continued  What would your approach be?  How might you combine approaches?

Further reading  ov/mcd/viewtechasse ss.asp?from2=viewte chassess.asp&where =index&tid=48& ov/mcd/viewtechasse ss.asp?from2=viewte chassess.asp&where =index&tid=48&  Or, go to and search for completed technology assesments in